CTLA4 and cancer: ,61 Other case reports of PWH on ART receiving anti-PD-1 or anti-CTLA-4 for cancer have described transient increases in either cell-associated or plasma HIV RNA with or without a decrease in the frequency of latently infected CD4+ T-cells,62,63 whereas others have not seen this effect.64